BamSEC and AlphaSense Join Forces
Learn More

Intercept Pharmaceuticals, Inc. – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 14 pages Intercept Pharmaceuticals, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 6 pages Amendment to the Agreement for the Supply of Manufactured Products
12/34/56
EX-10.1
from 8-K 17 pages Exchange Agreement
12/34/56
EX-10.16
from 10-Q 9 pages ​ Intercept Pharmaceuticals, Inc. Amended and Restated Equity Incentive Plan Performance Stock Unit Grant ​ Performance Stock Unit Grant Notice
12/34/56
EX-10.15
from 10-Q 6 pages Intercept Pharmaceuticals, Inc. Restricted Stock Unit Agreement - Incorporated Terms and Conditions
12/34/56
EX-10.14
from 10-Q 17 pages ​ Intercept Pharmaceuticals, Inc. Amended and Restated Equity Incentive Plan Restricted Stock Unit Grant ​ Restricted Stock Unit Grant Notice
12/34/56
EX-10.13
from 10-Q 10 pages Intercept Pharmaceuticals, Inc. ​ Stock Option Agreement - Incorporated Terms and Conditions
12/34/56
EX-10.12
from 10-Q 16 pages Intercept Pharmaceuticals, Inc. Amended and Restated Equity Incentive Plan Stock Option Grant ​ Stock Option Grant Notice
12/34/56
EX-10.11
from 10-Q 14 pages Intercept Pharmaceuticals, Inc. Amended and Restated Equity Incentive Plan
12/34/56
EX-10.10
from 10-Q 6 pages Dated 1 July 2022 Deed of Amendment Relating to the Share Purchase Agreement Dated 5 May 2022
12/34/56
EX-10.9
from 10-Q 4 pages Dated 1 July 2022 Deed of Amendment Relating to a Safety Data Exchange Agreement Dated 5 May 2022
12/34/56
EX-10.8
from 10-Q 7 pages Dated 26 July 2022 Deed of Amendment to the Transitional Services Agreement Dated 5 May 2022
12/34/56
EX-10.7
from 10-Q 7 pages [Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential.] Master Trademark Assignment Agreement
12/34/56
EX-10.6
from 10-Q 32 pages Transitional Services Agreement for the Provision and Use of Services and Reverse Services Intercept Pharmaceuticals, Inc. Advanz Pharma Services (Uk) Limited Date 5 May 2022 ​ ​ ​ ​ Contents
12/34/56
EX-10.5
from 10-Q 20 pages Safety Data Exchange Agreement
12/34/56
EX-10.4
from 10-Q 27 pages [Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential.] Dated5 May 2022
12/34/56
EX-10.3
from 10-Q 33 pages Agreement for the Supply of Manufactured Products
12/34/56
EX-10.2
from 10-Q 55 pages Sublicense Agreement by and Between Intercept Pharma Europe Ltd. and Mercury Pharma Group Limited Executed as of May 5, 2022 ​
12/34/56
EX-10.1
from 10-Q 96 pages Dated 5 May 2022
12/34/56
EX-10.4
from 10-Q 14 pages Employment Agreement
12/34/56